This article presents an investment case for advancing Ghana's reproductive health agenda, using nationally representative data and cost-benefit modelling to estimate the investments required and the expected health and economic returns from 2024 to 2030. The analysis identifies a substantial financing gap of USD 430 million under the ambitious scenario, while demonstrating the potential gains from scaling up evidence-based interventions. Expanded access to reproductive health services is projected to avert about 8 million unintended pregnancies and prevent 8,000 maternal deaths, yielding benefit-cost ratios of roughly 23:1 for family planning and 7:1 for maternal health. These returns represent an estimated twenty-fold gain on investment. Conversely, failure to invest risks forfeiting up to 1.6% of GDP in lost productivity. Overall, the findings show that investing in reproductive health is both a moral imperative and a sound economic strategy for sustainable development and gender equity in Ghana.
Novignon et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: